K Health Raises $50M in Funding

K Health

K Health, a NYC-based provider of an AI primary care platform, raised $50M in funding.

The round was led by Claure Group, with participation from investors including Pablo Legorreta (founder and CEO of Royalty Pharma), and existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP.

The company intends to use the funds to expand operations and its development efforts.

Led by CEO and Founder Allon Bloch, K Health is a AI-driven primary care company aiming to provide access to medical care at scale. Its platform includes a medical chat and AI predictive models based on large datasets to help physicians optimize diagnosis and treatment, and focus on patient care. The 24/7 virtual primary care solution is available to people in the U.S. through health systems and insurers, as well as through a direct-to-consumer mobile app.

Together with leading health systems, K Health has also been developing a comprehensive longitudinal care program that integrates virtual care with brick-and-mortar to create scalable access to primary care. This integrated care delivery model combines K’s primary care co-pilot, patients’ EMRs, and brick-and-mortar assets of the health system to navigate patients within a system, including diagnostic tests and specialty care.

Commenting on the news, Allon Bloch said: “K Health solves the need to make primary care visits highly personalized by giving doctors AI super powers that enable them to practice at the top of their license. Our primary care platform offers a concierge medical experience, with an assigned provider and 24/7 access to care. When partnered with leading health systems like Cedars-Sinai, this model creates significant benefits to access, clinical outcomes, and patient experience. All you need to get care is your health insurance, a stark contrast to concierge medicine services that typically cost thousands of dollars.